Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
43.79
+1.24 (2.91%)
At close: Mar 3, 2026, 4:00 PM EST
44.65
+0.86 (1.96%)
After-hours: Mar 3, 2026, 7:12 PM EST
Xenon Pharmaceuticals Market Cap
Xenon Pharmaceuticals has a market cap or net worth of $3.64 billion as of March 3, 2026. Its market cap has increased by 21.71% in one year.
Market Cap
3.64B
Enterprise Value
3.06B
1-Year Change
21.71%
Ranking
Category
Stock Price
$43.79
Market Cap Chart
Since November 5, 2014, Xenon Pharmaceuticals's market cap has increased from $142.20M to $3.64B, an increase of 2,461.82%. That is a compound annual growth rate of 33.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 3.54B | 2.20% |
| Dec 31, 2025 | 3.46B | 15.89% |
| Dec 31, 2024 | 2.99B | -0.83% |
| Dec 29, 2023 | 3.01B | 22.21% |
| Dec 30, 2022 | 2.47B | 53.02% |
| Dec 31, 2021 | 1.61B | 199.33% |
| Dec 31, 2020 | 538.40M | 58.77% |
| Dec 31, 2019 | 339.10M | 112.87% |
| Dec 31, 2018 | 159.30M | 213.58% |
| Dec 29, 2017 | 50.80M | -63.13% |
| Dec 30, 2016 | 137.80M | 19.20% |
| Dec 31, 2015 | 115.60M | -58.73% |
| Dec 31, 2014 | 280.10M | 96.98% |
| Nov 5, 2014 | 142.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACADIA Pharmaceuticals | 3.89B |
| Centessa Pharmaceuticals | 3.87B |
| Viking Therapeutics | 3.85B |
| Corcept Therapeutics | 3.83B |
| NewAmsterdam Pharma Company | 3.77B |
| Alumis | 3.70B |
| Legend Biotech | 3.41B |
| Spyre Therapeutics | 3.34B |